Wisconsin § 632.867 Oral and injected chemotherapy.

Wisconsin Statutes

§ 632.867 — Oral and injected chemotherapy.

Wisconsin § 632.867

Ch. 632Insurance contracts in specific lines

Subch.subch. VI of ch. 632 SUBCHAPTER VI

DISABILITY INSURANCE

This text of Wisconsin § 632.867 (Oral and injected chemotherapy.) is published on Counsel Stack Legal Research, covering Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Wis. Stat. § 632.867 (2026).

Text

632.867 632.867(1) (1) Definitions. In this section: 632.867(1)(a) (a) “Chemotherapy” means drugs and biologics that kill cancer cells directly, including antineoplastics, biologic response modifiers, hormone therapy, and monoclonal antibodies, and that are used to do any of the following: 632.867(1)(a)1.

1.Cure a specific cancer. 632.867(1)(a)2.

2.Control tumor growth when cure is not possible. 632.867(1)(a)3.

3.Shrink tumors before surgery or radiation therapy. 632.867(1)(a)4.

4.Destroy microscopic cancer cells that may be present after a tumor is removed by surgery to prevent a cancer recurrence. 632.867(1)(b) (b) “Disability insurance policy” has the meaning given in s. 632.895 (1) (a) . 632.867(1)(c) (c) “Self-insured health plan” has the meaning given in s. 632.85 (1) (c) . 632.8

Free access — add to your briefcase to read the full text and ask questions with AI

632.867
632.867(1) (1) Definitions. In this section:
632.867(1)(a) (a) “Chemotherapy” means drugs and biologics that kill cancer cells directly, including antineoplastics, biologic response modifiers, hormone therapy, and monoclonal antibodies, and that are used to do any of the following:
632.867(1)(a)1. 1. Cure a specific cancer.
632.867(1)(a)2. 2. Control tumor growth when cure is not possible.
632.867(1)(a)3. 3. Shrink tumors before surgery or radiation therapy.
632.867(1)(a)4. 4. Destroy microscopic cancer cells that may be present after a tumor is removed by surgery to prevent a cancer recurrence.
632.867(1)(b) (b) “Disability insurance policy” has the meaning given in s. 632.895 (1) (a) .
632.867(1)(c) (c) “Self-insured health plan” has the meaning given in s. 632.85 (1) (c) .
632.867(2) (2) Copayment, deductible, or coinsurance requirements; limitations.
632.867(2)(a) (a) Except as provided in par. (am) , a disability insurance policy that covers injected or intravenous chemotherapy and oral chemotherapy, or a self-insured health plan that covers injected or intravenous chemotherapy and oral chemotherapy, may not require a higher copayment, deductible, or coinsurance amount for oral chemotherapy than it requires for injected or intravenous chemotherapy, regardless of the formulation or benefit category determination by the policy or plan.
632.867(2)(am) (am) A disability insurance policy or self-insured health plan that limits copayments paid by a covered individual to no more than $100 for a 30-day supply of oral chemotherapy medication is considered to comply with this section. On January 1, 2016, and on each January 1 annually thereafter, a disability insurance policy or self-insured health plan may adjust the $100 limit under this paragraph by an amount that does not exceed the percentage increase in the U.S. consumer price index for all urban consumers, U.S. city average, as determined by the U.S. department of labor.
632.867(2)(b) (b) A disability insurance policy or a self-insured health plan may not comply with par. (a) by increasing the copayment, deductible, or coinsurance amount required for injected or intravenous chemotherapy that is covered under the policy or plan.
632.867(2)(c) (c) Notwithstanding par. (a) , for a disability insurance policy, or self-insured health plan, that is a high deductible health plan, as defined in 26 USC 223 (c) (2), par. (a) applies only after the plan enrollee’s deductible has been satisfied for the year.